Net Income (Loss) Attributable to Parent in USD of Medicus Pharma Ltd. from 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Medicus Pharma Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2023 to Q3 2025.
  • Medicus Pharma Ltd. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$20,935,753.000, a 819% decline year-over-year.
  • Medicus Pharma Ltd. annual Net Income (Loss) Attributable to Parent for 2024 was -$11,155,516.000, a 110% decline from 2023.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Medicus Pharma Ltd. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$20,935,753 -$18,657,006 -8.2% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q1 2025 -$5,102,408 -$3,395,050 -2% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q3 2024 -$2,278,747 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q1 2024 -$1,707,358 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025

Medicus Pharma Ltd. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11,155,516 -$5,840,751 -1.1% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 -$5,314,765 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.